Morin promotes the production of Th2 cytokine by modulating bone marrow-derived dendritic cells

American Journal of Chinese Medicine

Volumn 34, Issue 4, 2006, Pages 667-684

  Li, Chia Yang ^a   Suen, Jau Ling ^b   Chiang, Bor Luen ^c   Chao, Pei Dawn Lee ^a   Fang, Shih Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Dendritic cells; Helper T type 1 (Th1); Helper T type 2 (Th2); Morin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MORIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CELL FUNCTION; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; HELPER CELL; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ANTIOXIDANTS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH2 CELLS; TIME FACTORS;

EID: 33749462699     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06004193     Document Type: Article

References (63)

1. Akira, S., K. Takeda and T. Kaisho. Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680, 2001.
2. Banchereau, J. and R.M. Steinman. Dendritic cells and the control of immunity. Nature 392: 245-252, 1998.
3. Bhattacharya, R.K. and P.F. Firozi. Effect of plant flavonoids on microsome catalyzed reactions of aflatoxin B1 leading to activation and DNA adduct formation. Cancer Lett. 39: 85-91, 1988.
4. Braat, H., M.P. Peppelenbosch and D.W. Hommes. Interleukin-10-based therapy for inflammatory bowel disease. Expert. Opin. Biol. Ther. 3: 725-731, 2003.
5. Byl, B., M. Libin, J. Bauer, O.R. Martin, D. De Wit, G. Davies, M. Goldman and F. Willems. OM197-MP-AC induces the maturation of human dendritic cells and promotes a primary T cell response. Int. Immunopharmacol. 3: 417-425, 2003.
6. Cella, M., F. Facchetti, A. Lanzavecchia and M. Colonna. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1: 305-310, 2000.
7. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen and A. Lanzavecchia. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189: 821-829, 1999.
8. Cella, M., F. Sallusto and A. Lanzavecchia. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9: 10-16, 1997.
9. Fang, S.H., Y.C. Hou, W.C. Chang, S.L. Hsiu, P.D. Chao and B.L. Chiang. Morin sulfates/ glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci. 74: 743-756, 2003.
10. Fang, S.H., L.H. Hwang, D.S. Chen and B.L. Chiang. Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J. Hepatol. 33: 791-798, 2000.
11. Flohe, S.B., J. Bruggemann, S. Lendemans, M. Nikulina, G. Meierhoff, S. Flohe and H. Kolb. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170: 2340-2348, 2003.
12. Forchhammer, L., M. Thorn, O. Met, M. Gad, M.S. Weidner and M.H. Claesson. Immunobiological effects of glucosamine in vitro. Scand. J. Immunol. 58: 404-411, 2003.
13. Francis, A.R., T.K. Shetty and R.K. Bhattacharya. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis 10: 1953-1955, 1989.
14. Gagliardi, M.C., F. Sallusto, M. Marinaro, A. Langenkamp, A. Lanzavecchia and M.T. De Magistris. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30: 2394-2403, 2000.
15. Gately, M.K. Interleukin-12: Potential clinical applications in the treatment of chronic viral hepatitis. J. Viral Hepat. 4 Suppl 1: 33-39, 1997.
16. Gately, M.K. and M.J. Mulqueen. Interleukin-12: Potential clinical applications in the treatment and prevention of infectious diseases. Drugs 52 Suppl 2: 18-25; discussion 25-26, 1996.
17. Gately, M.K., L.M. Renzetti, J. Magram, A.S. Stern, L. Adorini, U. Gubler and D.H. Presky. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu. Rev. Immunol. 16: 495-521, 1998.
18. Guha, M. and N. Mackman. LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001.
19. Hanasaki, Y., S. Ogawa and S. Fukui. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic. Biol. Med. 16: 845-850, 1994.
20. Heystek, H.C., B. den Drijver, M.L. Kapsenberg, R.A. van Lier and E.C. de Jong. Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-gamma-mediated signaling. Clin. Immunol. 107: 170-177, 2003a.
21. Heystek, H.C., A.C. Thierry, P. Soulard and C. Moulon. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity. Int. Immunol. 15: 827-835, 2003b.
22. Hilkens, C.M., P. Kalinski, M. de Boer and M.L. Kapsenberg. Human dendritic cells require exogenous interleukin-l2-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90: 1920-1926, 1997.
23. Hou, W., Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong and B. Sun. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J. Immunol. 170: 1728-1736, 2003a.
24. Hou, Y.C., P.D. Chao, H.J. Ho, C.C. Wen, and S.L. Hsiu. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J. Pharm. Pharmacol. 55: 199-203, 2003b.
25. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu and R.M. Steinman. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-702, 1992.
26. Inaba, K., J.P. Metlay, M.T. Crowley, M. Witmer-Pack and R.M. Steinman. Dendritic cells as antigen presenting cells in vivo. Int. Rev. Immunol. 6: 197-206, 1990.
27. Inaba, K. and R.M. Steinman. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J. Exp. Med. 160: 1717-1735, 1984.
28. Jonuleit, H., E. Schmitt, K. Steinbrink and A.H. Enk. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22: 394-400, 2001.
29. Kadowaki, N., S. Antonenko, J.Y. Lau and Y.J. Liu. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192: 219-226, 2000.
30. Kalinski, P., C.M. Hilkens, E.A. Wierenga and M.L. Kapsenberg. T-cell priming by type-1 and type-2 polarized dendritic cells: The concept of a third signal. Immunol. Today 20: 561-567, 1999.
31. Kalinski, P., J.H. Schuitemaker, C.M. Hilkens, and M.L. Kapsenberg. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J. Immunol. 161: 2804-2809, 1998.
32. Kelleher, P., A. Maroof and S.C. Knight. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur. J. Immunol. 29: 2309-2318, 1999.
33. Kiemer, A.K., A.M. Vollmar, M. Bilzer, T. Gerwig and A.L. Gerbes. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J. Hepatol. 33: 236-246, 2000.
34. Kim, H.K., B.S. Cheon, Y.H. Kim, S.Y. Kim and H.P. Kim. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58: 759-765, 1999.
35. Knight, S.C. Control of lymphocyte stimulation in vitro: "help" and "suppression" in the light of lymphoid population dynamics. J. Immunol. Methods 50: R51-63, 1982.
36. Kok, L.D., Y.P. Wong, T.W. Wu, H.C. Chan, T.T. Kwok and K.P. Fung. Morin hydrate: A potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs. Life Sci. 67: 91-99, 2000.
37. Larsen, C.P., S.C. Ritchie, T.C. Pearson, P.S. Linsley and R.P. Lowry. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176: 1215-1220, 1992.
38. Lechler, R., W.F. Ng and R.M. Steinman. Dendritic cells in transplantation - friend or foe? Immunity 14: 357-368, 2001.
39. Lenschow, D.J., K.C. Herold, L. Rhee, B. Patel, A. Koons, H.Y. Qin, E. Fuchs, B. Singh, C.B. Thompson and J.A. Bluestone. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293, 1996.
40. Ludewig, B., B. Odermatt, A.F. Ochsenbein, R.M. Zinkernagel and H. Hengartner. Role of dendritic cells in the induction and maintenance of autoimmune diseases. Immunol. Rev. 169: 45-54, 1999.
41. Macatonia, S.E., P.M. Taylor, S.C. Knight, and B.A. Askonas. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169: 1255-1264, 1989.
42. Maldonado-Lopez, R. and M. Moser. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin. Immunol. 13: 275-282, 2001.
43. Medzhitov, R. and C. Janeway, Jr. The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-456, 2000.
44. Morita, R., N. Ukyo, M. Furuya, T. Uchiyama and T. Hori. Atrial natriuretic peptide polarizes human dendritic cells toward a Th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor A. J. Immunol. 170: 5869-5875, 2003.
45. Moskaug, J.O., H. Carlsen, M. Myhrstad and R. Blomhoff. Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev. 125: 315-324, 2004.
46. Mosmann, T.R. and S. Sad. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146, 1996.
47. Palanivel, V., C. Posey, A.M. Horauf, W. Solbach, W.F. Piessens and D.A. Harn. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp. Parasitol. 84: 168-177, 1996.
48. Ramanathan, L., N.P. Das and Q.T. Li. Studies on lipid oxidation in fish phospholipid liposomes. Biol. Trace Elem. Res. 40: 59-70, 1994.
49. Raso, G.M., R. Meli, G. Di Carlo, M. Pacilio and R. Di Carlo. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci. 68: 921-931, 2001.
50. Reis e Sousa, C., A. Sher and P. Kaye. The role of dendritic cells in the induction and regulation of immunity to microbial infection. Curr. Opin. Immunol. 11: 392-399, 1999.
51. Rescigno, M., M. Martino, C.L. Sutherland, M.R. Gold and P. Ricciardi-Castagnoli. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180, 1998.
52. Schweitzer, A.N., F. Borriello, R.C. Wong, A.K. Abbas and A.H. Sharpe. Role of costimulators in T cell differentiation: Studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158: 2713-2722, 1997.
53. Seldon, P.M., P.J. Barnes, K. Meja and M.A. Giembycz. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Mol. Pharmacol. 48: 747-757, 1995.
54. Sornasse, T., V. Flamand, G. De Becker, H. Bazin, F. Tielemans, K. Thielemans, J. Urbain, O. Leo and M. Moser. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J. Exp. Med. 175: 15-21, 1992.
55. Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296, 1991.
56. Stern, A.S., J. Magram, and D.H. Presky. Interleukin-12 an integral cytokine in the immune response. Life Sci. 58: 639-654, 1996.
57. Suen, J.L., Y.H. Chuang, and B.L. Chiang. In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: The induction of a high level of autoantibodies but not renal pathological changes. Immunology 106: 326-335, 2002.
58. Velupillai, P. and D.A. Harn. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc. Natl. Acad. Sci. USA 91: 18-22, 1994.
59. Vieira, P.L., E.C. de Jong, E.A. Wierenga, M.L. Kapsenberg and P. Kalinski. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164: 4507-4512, 2000.
60. Vieira, P.L., H.C. Heystek, J. Wormmeester, E.A. Wierenga and M.L. Kapsenberg. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170: 4483-4488, 2003.
61. Wang, Y., C.G. Kelly, M. Singh, E.G. McGowan, A.S. Carrara, L.A. Bergmeier and T. Lehner. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169: 2422-2429, 2002.
62. Whelan, M., M.M. Harnett, K.M. Houston, V. Patel, W. Harnett and K.P. Rigley. A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J. Immunol. 164: 6453-6460, 2000.
63. Winzler, C., P. Rovere, V.S. Zimmermann, J. Davoust, M. Rescigno, S. Citterio and P. Ricciardi-Castagnoli. Checkpoints and functional stages in DC maturation. Adv. Exp. Med. Biol. 417: 59-64, 1997.